The present disclosure relates to inhalable pharmaceuticals. Specifically, thepresent disclosure relates to a composition comprising inhalable microparticlescomprising hydroxychloroquine, aspirin, a copolymer and at least one surfactant.Further, the present invention also relates to a process of preparing the same. The10 composition of the present invention may be used for management of acuterespiratory disease and cardiovascular complications associated with COVID andSARS.
Inventors
Sandeep Arora, Sukhbir Singh, Neelam Sharma
